Polaris Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-100
| Closed | -$9.07K | – | 98 |
|
|
2022
Q4 | $9.07K | Hold |
100
| – | – | ﹤0.01% | 96 |
|
|
2022
Q3 | $8K | Hold |
100
| – | – | ﹤0.01% | 100 |
|
|
2022
Q2 | $8K | Hold |
100
| – | – | ﹤0.01% | 101 |
|
|
2022
Q1 | $9K | Buy |
+100
| New | +$8.66K | ﹤0.01% | 103 |
|
|
2021
Q4 | – | Sell |
-500
| Closed | -$41K | – | 107 |
|
|
2021
Q3 | $41K | Hold |
500
| – | – | ﹤0.01% | 102 |
|
|
2021
Q2 | $46K | Hold |
500
| – | – | ﹤0.01% | 101 |
|
|
2021
Q1 | $44K | Hold |
500
| – | – | ﹤0.01% | 102 |
|
|
2020
Q4 | $47K | Hold |
500
| – | – | ﹤0.01% | 100 |
|
|
2020
Q3 | $43K | Hold |
500
| – | – | ﹤0.01% | 99 |
|
|
2020
Q2 | $44K | Hold |
500
| – | – | ﹤0.01% | 101 |
|
|
2020
Q1 | $41K | Hold |
500
| – | – | ﹤0.01% | 101 |
|
|
2019
Q4 | $47K | Hold |
500
| – | – | ﹤0.01% | 87 |
|
|
2019
Q3 | $43K | Hold |
500
| – | – | ﹤0.01% | 82 |
|
|
2019
Q2 | $46K | Sell |
500
-58
| -10% | -$4.91K | ﹤0.01% | 82 |
|
|
2019
Q1 | $48K | Hold |
558
| – | – | ﹤0.01% | 83 |
|
|
2018
Q4 | $43K | Hold |
558
| – | – | ﹤0.01% | 85 |
|
|
2018
Q3 | $43K | Hold |
558
| – | – | ﹤0.01% | 85 |
|
|
2018
Q2 | $38K | Hold |
558
| – | – | ﹤0.01% | 86 |
|
|
2018
Q1 | $40K | Hold |
558
| – | – | ﹤0.01% | 87 |
|
|
2017
Q4 | $42K | Hold |
558
| – | – | ﹤0.01% | 87 |
|
|
2017
Q3 | $43K | Hold |
558
| – | – | ﹤0.01% | 88 |
|
|
2017
Q2 | $42K | Hold |
558
| – | – | ﹤0.01% | 87 |
|
|
2017
Q1 | $37K | Hold |
558
| – | – | ﹤0.01% | 89 |
|
|
2016
Q4 | $36K | Hold |
558
| – | – | ﹤0.01% | 90 |
|
|
2016
Q3 | $39K | Hold |
558
| – | – | ﹤0.01% | 98 |
|
|
2016
Q2 | $41K | Sell |
558
-112
| -17% | -$7.74K | ﹤0.01% | 96 |
|
|
2016
Q1 | $46K | Hold |
670
| – | – | ﹤0.01% | 100 |
|
|
2015
Q4 | $52K | Hold |
670
| – | – | 0.01% | 98 |
|
|
2015
Q3 | $55K | Hold |
670
| – | – | 0.01% | 107 |
|
|
2015
Q2 | $59K | Hold |
670
| – | – | 0.01% | 107 |
|
|
2015
Q1 | $59K | Hold |
670
| – | – | 0.01% | 104 |
|
|
2014
Q4 | $56K | Hold |
670
| – | – | 0.01% | 51 |
|
|
2014
Q3 | $56K | Hold |
670
| – | – | 0.01% | 52 |
|
|
2014
Q2 | $54K | Buy |
+670
| New | +$52.7K | 0.01% | 49 |
|
Other funds holding NVS
Polaris Capital Management's NVS Position: Q1 2023 in Review
Polaris Capital Management sold out of Novartis (NVS) in Q1 2023, closing a stake of 100 shares — an estimated $9.07K sold.
Polaris Capital Management first reported a position in NVS in Q2 2014 and held it in 34 quarters. The position peaked at $59K in Q2 2015. 1,180 funds tracked by Wall St. Rank hold NVS as of Q1 2023.
- Polaris Capital Management reported no remaining Novartis position as of Q1 2023 after selling out during the quarter.
- Polaris Capital Management sold 100 Novartis shares in Q1 2023, an estimated $9.07K.
- Polaris Capital Management first reported a position in Novartis in Q2 2014 and held it in 34 quarters.
- Polaris Capital Management's Novartis position peaked at $59K in Q2 2015.
- 1,180 funds tracked by Wall St. Rank held Novartis as of Q1 2023.
Based on Polaris Capital Management's 13F filing for Q1 2023, filed 28 Apr 2023.